Likewise, only MLKL-mRNA treatment resulted in significant numbers of interferon-γ (IFN-γ) producing OVA-peptide-specific CD4+ and CD8+ T cells in the tumor draining lymph node (Fig. 7b). The gene discussed is MLKL; the disease is neoplasm.